When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IPSEY - Crinetics Pharmaceuticals- Superior Molecules In Endocrinology
Ipsen SA ADR
Crinetics Pharmaceuticals (CRNX) has a lead molecule, paltusotine, that may be best in class. Phase 2 testing is on track to be completed in Q4 2020 and may act as a catalyst for the stock to move up if the data is positive. Peak sales potential for paltusotine, if approved, could reach $1.5 billion annually. Results are somewhat binary in that failure of the lead molecule would significantly impact the company’s value. Crinetics offers a reasonable risk reward profile in that it has a pipeline of molecules, its lead program has produced favorable